Roche

Roche, Blueprint Medicines sign $1.7bn worth deal for pralsetinib
Pharmaceutical Business Review
Tue, 07/14/20 - 10:29 am
Roche
Blueprint Medicines
pralsetinib
RET-altered cancer
Genentech's Tecentriq-Avastin Combo Fails to Hit Primary Endpoint in Ovarian Cancer
BioSpace
Mon, 07/13/20 - 12:15 pm
Genentech
Roche
clinical trials
Tecentriq
ovarian cancer
Roche targets 2021 start for hemophilia A gene therapy phase 3 as optimization effort drags on
Fierce Biotech
Mon, 07/13/20 - 11:11 am
Roche
hemophilia A
Spark Therapeutics
SPK-8011
FDA bars the door — for now — against Merck’s star cancer drug after Roche beat them to the punch
Endpoints
Wed, 07/8/20 - 10:43 am
Merck
FDA
complete response letter
Keytruda
Eisaid
Lenvima
hepatocellular carcinoma
Roche
Roche Gets FDA OK for Injectable Version of Breast Cancer Drug
Xconomy
Mon, 06/29/20 - 11:59 pm
Roche
HER2+ breast cancer
FDA
Phesgo
Roche, BioNTech post 'low' response rate in cancer vaccine trial
Fierce Biotech
Mon, 06/22/20 - 11:13 am
Roche
BioNTech
vaccines
personalized medicine
clinical trials
RO7198457
Roche phase 3 hits goal in subgroup of prostate cancer patients
Fierce Biotech
Fri, 06/19/20 - 11:29 am
Roche
clinical trials
Ipatasertib
prostate cancer
The ipatasertib curate’s egg
EP Vantage
Fri, 06/19/20 - 10:45 am
Roche
akt protein inhibitor
prostate cancer
Ipatasertib
Roche's Checkpoint Inhibitor Hits the Mark in Early Triple-Negative Breast Cancer Study
BioSpace
Thu, 06/18/20 - 08:38 pm
Roche
Genentech
Tecentriq
triple negative breast cancer
clinical trials
Celgene
Abraxane
Roche's Actemra falls short in Italian study in early-stage COVID-19 pneumonia
Fierce Pharma
Thu, 06/18/20 - 08:33 pm
Roche
Actgemra
COVID-19 pneumonia
COVID-19
clinical trials
NICE backs funding for Roche’s lung cancer drug after price cut
Pharmaforum
Mon, 06/15/20 - 10:21 am
NICE
Roche
Rozlytrek
non-small cell lung cancer
EHA: AbbVie, Roche cement Venclexta's place in AML with survival win
Fierce Pharma
Sat, 06/13/20 - 11:32 pm
AbbVie
Roche
Venclexta
AML
EHA
OptumRx: The 3 drugs that will have the biggest impact on payers, patients in 2020
Beckers Hospital Review
Thu, 06/11/20 - 10:46 pm
OptumRx
Roche
PTC Therapeutics
risdiplam
SMA
NS Pharma
viltolarsen
Duchenne Muscular Dystrophy
Immunomedics
Trodelvy
triple negative breast cancer
Roche pens $2B biobucks pact with Innovent Biologics for bispecific and cell therapies
Fierce Biotech
Tue, 06/9/20 - 12:17 pm
Roche
Innovent Biologics
China
bispecific antibodies
cell therapy
Drug manufacturing giant Lonza taps Roche/pharma ‘reinvention’ vet as its new CEO
Endpoints
Fri, 06/5/20 - 10:34 am
Lonza
Pharma CEOs
Roche
Pierre-Alain Ruffieux
drug manufacturing
FDA clears emergency use of Roche test for COVID-19 ‘cytokine storm’
Pharmaforum
Thu, 06/4/20 - 10:53 am
Roche
diagnostics
COVID-19
FDA
cytokine storm
Roche nabs frontline OK for Avastin/Tecentriq in common liver cancer, besting an old Bayer drug
Endpoints
Mon, 06/1/20 - 10:24 am
Roche
Avastin
Tecentriq
metastatic hepatocellular carcinoma
liver cancer
FDA
Roche and Gilead Launch COVID-19 Trial to Test One-Two Punch of Actemra and Remdesivir
BioSpace
Thu, 05/28/20 - 10:59 pm
Roche
Gilead Sciences
clinical trials
Actemra
RoActemra
remdesivir
COVID-19
pneumonia
COVID-19 pneumonia
Roche signs up with Oncimmune to explore immunotherapy responses
Pharmaforum
Thu, 05/28/20 - 10:36 am
Roche
Oncimmune
autoantibodies
immunotherapy
Roche beefs up diagnostic arm with another bet on faster, cheaper DNA sequencing
Endpoints
Fri, 05/22/20 - 10:56 am
Roche
Stratos Genomics
DNA
M&A
DNA sequencing

Pages